p53 promotes selection for Fas-mediated apoptotic resistance

被引:0
|
作者
Maecker, HL
Koumenis, C
Giaccia, AJ
机构
[1] Stanford Univ, Med Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27157 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although p53 inactivation is implicated as a mechanism to explain diminished apoptotic response, it is clear that tumor cells that possess transcriptionally functional p53 can also be resistant to diverse apoptotic stimuli, We hypothesize that oncogenic activation and DNA damage are sufficient stimuli to increase the p53-dependent transcription of Fas and thereby establish a situation in which cell to cell contact could be a selective pressure to either lose p53 function or inactivate components of the Fas death pathway. Examination of genetically matched tumor cell lines that possessed either wild-type or null p53 loci indicated that cells possessing functional p53 increased their surface levels of Fas and Fas ligand (FasL) in response to DNA damage. In contrast, stress induced by changes in the tumor microenvironment such as decreased oxygen did not up-regulate Fas or Fast. Cells with wild-type p53 underwent Fas-mediated killing in the presence of either Fast-expressing killer cells or activating Fas antibodies, whereas cells in which p53 was deleted or inactivated were protected from such killing. Furthermore, Fas and Fast expression and induction became transcriptionally repressed in transformed cells with wild-type p53 with increasing passage, whereas other p53 downstream targets and functions, such as p21 inducibility and cell cycle arrest, remained intact. Repression of the Fas Locus could be reverted by treatment with the histone deacetylase inhibitor trichostatin A. These results support a model of tumor progression in which oncogenic transformation drives tumor cells to lose either p53 or their Fas sensitivity as a means of promoting their survival and evade immune surveillance.
引用
收藏
页码:4638 / 4644
页数:7
相关论文
共 50 条
  • [31] CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF
    L Kadaja-Saarepuu
    S Laos
    K Jääger
    J Viil
    A Balikova
    M Lõoke
    G C Hansson
    T Maimets
    Oncogene, 2008, 27 : 1705 - 1715
  • [32] Knockdown of RCAN1.4 Increases Susceptibility to FAS-mediated and DNA-damage-induced Apoptosis by Upregulation of p53 Expression
    Kim, Young Sun
    Lee, Hong Joon
    Jang, Chorong
    Kim, Ho-Shik
    Cho, Young-Jin
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2009, 13 (06): : 483 - 489
  • [33] Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death
    T Hashimoto
    K Juso
    M Nakano
    T Nagano
    S Kambayashi
    A Nakashima
    U Kikkawa
    S Kamada
    Cell Death & Disease, 2012, 3 : e313 - e313
  • [34] Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death
    Hashimoto, T.
    Juso, K.
    Nakano, M.
    Nagano, T.
    Kambayashi, S.
    Nakashima, A.
    Kikkawa, U.
    Kamada, S.
    CELL DEATH & DISEASE, 2012, 3 : e313 - e313
  • [35] INDUCTION OF FAS-MEDIATED APOPTOSIS IN P53-TRANSFECTED HUMAN COLON-CARCINOMA CELLS
    TAMURA, T
    AOYAMA, N
    SAYA, H
    HAGA, H
    FUTAMI, S
    MIYAMOTO, M
    KOH, T
    ARIYASU, T
    TACHI, M
    KASUGA, M
    TAKAHASHI, R
    ONCOGENE, 1995, 11 (10) : 1939 - 1946
  • [36] Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
    M Zhou
    L Gu
    AM Yeager
    HW Findley
    Leukemia, 1998, 12 : 1756 - 1763
  • [37] Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
    Zhou, M
    Gu, L
    Yeager, AM
    Findley, HW
    LEUKEMIA, 1998, 12 (11) : 1756 - 1763
  • [38] Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis
    Wang, Juan
    Cao, Zeyuan
    Wang, Panpan
    Zhang, Xiao
    Tang, Jianxia
    He, Yifan
    Huang, Zhiqing
    Mao, Xueli
    Shi, Songtao
    Kou, Xiaoxing
    ACS NANO, 2021, 15 (09) : 14360 - 14372
  • [39] Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway
    Kamada, S
    Washida, M
    Hasegawa, J
    Kusano, H
    Funahashi, Y
    Tsujimoto, Y
    ONCOGENE, 1997, 15 (03) : 285 - 290
  • [40] Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway
    Shinji Kamada
    Miwa Washida
    Jun-ichi Hasegawa
    Hajime Kusano
    Yoshimitsu Funahashi
    Yoshihide Tsujimoto
    Oncogene, 1997, 15 : 285 - 290